Absci Corp.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Absci Corp. - overview
Established
2011
Location
Vancouver, WA, US
Primary Industry
Biotechnology
About
Based in Washington, US, Absci Corp, formerly known as Absci LLC, was founded in 2011 by founder Jeremy Abelson. The company provides a deep learning-based biologics platform for drug creation and cell line development. In March 2021, AbSci, LLC raised USD 125 million in venture funding co-led by Casdin Capital and Redmile Group, with participation from ArrowMark Partners. In July 2021, Absci raised USD 200 million by offering 12.
5 million shares on the Nasdaq under the ticker symbol ABSI, and as of this date, the company has 169 employees. In January 2025, Absci Corp. raised USD 20 million PIPE funding from AMD. The company works with biopharmaceutical companies by offering an integrated biology platform, a protein printing platform technology for protein engineering.
Absci Corp screens novel drug variants based on the desired scaffold format and cell line used for manufacturing and streamlines the drug formulation process. The company also offers SoluPro, a platform for complex disulfide-bonded proteins in a soluble form, and SoluPure, a purification technology that eliminates downstream chromatography steps in the drug formulation process. The company will use the funding to strengthen artificial intelligence-driven drug discovery capabilities and expand the deployment of AMD hardware and software solutions in critical workloads.
Current Investors
Phoenix Venture Partners, AGC, Oregon Venture Fund
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Medical Software
Website
www.absci.com/
Verticals
Artificial Intelligence, HealthTech
Company Stage
Mature
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.